Sandoz, the pioneer and global leader in biosimilars.

Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars. It is the pioneer and global leader in biosimilars. In Canada, Sandoz markets six products: Omnitrope®, Erelzi®, Zientenzo®, Riximyo®, Hyrimoz® and Inclunox®.

As a division of the Novartis Group, Sandoz is well-positioned to lead the biosimilars industry based on its experience and capabilities in development, manufacturing, and commercialization.

Visit The Biosimilars Generation website to learn more.

Are you a dermatologist or a family physician?

Enjoy a complimentary e-subscription to SkinTherapyLetter®, a prestigious Dermatology journal indexed with the National Library in Washington.

Subscribe Today!